Jiangsu Hengrui Medicine
600276.SS
#460
Rank
HK$344.34 B
Marketcap
HK$53.98
Share price
-0.54%
Change (1 day)
5.12%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : HK$53.66 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are HK$53.66 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31HK$47.98 B-0.14%
2021-12-31HK$48.05 B16.4%
2020-12-31HK$41.27 B34.36%
2019-12-31HK$30.72 B19.85%
2018-12-31HK$25.63 B18.32%
2017-12-31HK$21.66 B35.37%
2016-12-31HK$16.00 B16.4%
2015-12-31HK$13.74 B20.78%
2014-12-31HK$11.38 B23.04%
2013-12-31HK$9.25 B26.29%
2012-12-31HK$7.32 B23.04%
2011-12-31HK$5.95 B29.86%
2010-12-31HK$4.58 B34.68%
2009-12-31HK$3.40 B33.14%
2008-12-31HK$2.55 B16.23%
2007-12-31HK$2.19 B50.35%
2006-12-31HK$1.46 B18.46%
2005-12-31HK$1.23 B4.65%
2004-12-31HK$1.18 B-13.24%
2003-12-31HK$1.36 B19.85%
2002-12-31HK$1.13 B7.65%
2001-12-31HK$1.05 B